Skip to main content

Table 4 Multivariate analysis of disease free survival among patients with baseline BMI ≥ 23 kg/m2 (N = 338)

From: Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients

   Adjusted HR (95 % CI) p-value
Body weight change Gain ≥ 5 kg 2.04 (1.02–4.08) 0.043
Others 1  
Angiolymphatic invasion Present 2.61 (1.37–4.94) 0.003
Absent 1  
Perineural invasion Present 2.51 (1.43–4.38) 0.001
Absent 1  
T stage T 4 1.99 (1.05–3.76) 0.035
T 1–3 1  
N stage N 2 2.34 (1.35–4.06) 0.002
N 0–1 1  
  1. Abbreviations: HR hazard ratio, CI confidence interval